Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis
Antimicrobial Agents and Chemotherapy · 24.01.2023 · 67 (1)
DOI: 10.1128/aac.01140-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 24.01.2023. Verfasst von Ana-Katharina E Gehrke und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Estudios Biomédicos, Básicos, Aplicados y Desarrollo (CEBBAD), Departamento de Investigaciones Biomédicas y Biotecnológicas, Universidad Ma…. Hauptthemen laut MEDLINE: Osteomyelitis, Staphylococcal Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Fundacion Cientifica Felipe Fiorellino, Burroughs Wellcome Fund and by the G. Harold and Leila Y. Mathers Charitable Foundation.
Abstract (Originalsprache)
Osteomyelitis caused by Staphylococcus aureus is an important and current health care problem worldwide. Treatment of this infection frequently fails not only due to the increasing incidence of antimicrobial-resistant isolates but also because of the ability of S. aureus to evade the immune system, adapt to the bone microenvironment, and persist within this tissue for decades.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Estudios Biomédicos, Básicos, Aplicados y Desarrollo (CEBBAD), Departamento de Investigaciones Biomédicas y Biotecnológicas, Universidad Maimónides, Buenos Aires, Argentina.
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
- Instituto de investigaciones en Microbiología y Parasitología Médica (IMPaM), Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
- Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: James E Cassat, Marisa I Gómez
Förderung
- NIAID NIH HHS
- Fundacion Cientifica Felipe Fiorellino
- Burroughs Wellcome Fund and by the G. Harold and Leila Y. Mathers Charitable Foundation
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- MINCyT | Agencia Nacional de Promoción Científica y Tecnológica
Zitieren
APA
Gehrke, A. E., Mendoza-Bertelli, A., Ledo, C., Gonzalez, C. D., Noto Llana, M., Blanco, C., Sordelli, D. O., Putman, N. E., Cassat, J. E., Delpino, M. V., & Gómez, M. I. (2023). Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis. Antimicrobial Agents and Chemotherapy, 67(1). https://doi.org/10.1128/aac.01140-22
Vancouver
Gehrke AE, Mendoza-Bertelli A, Ledo C, Gonzalez CD, Noto Llana M, Blanco C, et al. Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis. Antimicrobial Agents and Chemotherapy. 2023;67(1). doi:10.1128/aac.01140-22
BibTeX
@article{Gehrke2023,
author = {Gehrke, Ana-Katharina E and Mendoza-Bertelli, Andrea and Ledo, Camila and Gonzalez, Cintia D and Noto Llana, Mariángeles and Blanco, Cintia and Sordelli, Daniel O and Putman, Nicole E and Cassat, James E and Delpino, María Victoria and Gómez, Marisa I},
title = {Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {1},
doi = {10.1128/aac.01140-22}
}
EUVIMED